Fluorobexarotene

CAS No. 1190848-23-7

Fluorobexarotene( —— )

Catalog No. M32926 CAS No. 1190848-23-7

Fluorobexarotene possesses an apparent RXR binding affinity that is 75% greater than Bexarotene.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 278 Get Quote
5MG 440 Get Quote
10MG 649 Get Quote
25MG 984 Get Quote
50MG 1334 Get Quote
100MG 1755 Get Quote
500MG 3501 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Fluorobexarotene
  • Note
    Research use only, not for human use.
  • Brief Description
    Fluorobexarotene possesses an apparent RXR binding affinity that is 75% greater than Bexarotene.
  • Description
    Fluorobexarotene (compound 20) is a potent retinoid-X-receptor (RXR) agonist, with a Ki value of 12 nM and an EC50 value of 43 nM for RXRα receptor. Fluorobexarotene possesses an apparent RXR binding affinity that is 75% greater than Bexarotene.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Retinoid Receptor
  • Recptor
    Retinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1190848-23-7
  • Formula Weight
    366.47
  • Molecular Formula
    C24H27FO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 36 mg/mL (98.23 mM )
  • SMILES
    CC1=CC2=C(C=C1C(=C)C1=CC(F)=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wagner CE, et al. Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene). J Med Chem. 2009 Oct?
molnova catalog
related products
  • BMS493

    BMS493 is an inverse agonist of the pan-retinoic acid receptor (RAR) that inhibits retinoic acid-induced differentiation, enhances the interaction of nuclear co-inhibitors with RARs, attenuates RA signaling, potentiates TPP-induced toxicity, and inhibits the increase in phospholipase A2 activity.

  • Bexarotene

    Bexarotene is a retinoid specifically selective for retinoid X receptors, used as an oral antineoplastic agent in the treatment of cutaneous T-cell lymphoma.

  • Sodium sulfadiazine

    Sodium Sulfadiazine is a sodium salt form of sulfadiazine, an intermediate-acting bacteriostatic, synthetic sulfanilamide derivative.